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Abstract
Purpose: Patient tolerability of magnetic resonance (MR)−guided radiation treatment delivery is limited by the need for repeated deep
inspiratory breath holds (DIBHs). This volunteer study assessed the feasibility of continuous positive airway pressure (CPAP) with and
without DIBH for respiratory motion management during radiation treatment with an MR-linear accelerator (MR-linac).
Methods and Materials: MR imaging safety was ﬁrst addressed by placing the CPAP device in an MR-safe closet and conﬁguring a
tube circuit via waveguide to the magnet bore. Reproducibility and linearity of the ﬁnal conﬁguration were assessed. Six healthy
volunteers underwent thoracic imaging in a 0.35T MR-linac, with one free breathing (FB) and 2 DIBH acquisitions being obtained at 5
pressures from 0 to 15 cm-H2O. Lung and heart volumes and positions were recorded; repeatability was assessed by comparing 2
consecutive DIBH scans. Blinded reviewers graded images for motion artifact using a 3-point grading scale. Participants completed
comfort and perception surveys before and after imaging sessions.
Results: Compared with FB alone, FB-10, FB-12, and FB-15 cm H2O signiﬁcantly increased lung volumes (+23%, +34%, +44%; all
P <.05) and inferiorly displaced the heart (0.86 cm, 0.96 cm, 1.18 cm; all P < . 05). Lung volumes were signiﬁcantly greater with DIBH0 cm H2O compared with FB-15 cm H2O (+105% vs +44%, P = .01), and DIBH-15 cm H2O yielded additional volume increase
(+131% vs +105%, P = .01). Adding CPAP to DIBH decreased lung volume differences between consecutive breath holds (correlation
coefﬁcient 0.97 at 15 cm H2O vs 0.00 at 0 cm H2O). The addition of 15 cm H2O CPAP reduced artifact scores (P = .03) compared with
FB; all DIBH images (0-15 cm H2O) had less artifact (P < .01).
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Conclusions: This work demonstrates the feasibility of integrating CPAP in an MR-linac environment in healthy volunteers.
Extending this work to a larger patient cohort is warranted to further establish the role of CPAP as an alternative and concurrent
approach to DIBH in MR-guided radiation therapy.
© 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction
Deep inspiratory breath hold (DIBH) has been a clinically validated approach for the management of respiratory motion during the delivery of radiation therapy.
During DIBH, lung volume increases, resulting in 2 major
beneﬁts: (1) targets typically affected by respiration (ie,
lung, breast, liver, or abdominal lesions) have reduced
excursion, thereby reducing the overall target volume
requiring radiation; and (2) sensitive organs at risk such
as the heart move away from the radiation treatment
ﬁelds, thus reducing the dose.1,2 Although dosimetrically
favorable, DIBH requires a high degree of patient cooperation to successfully deliver. Furthermore, it is time consuming and its use increases treatment delivery times.3
Many clinics use additional techniques such as active
breathing control or spirometers to improve repeatability of
breath holds.4 However, this strategy depends on patient
compliance, involves longer treatment times, and uses more
clinical resources.4,5 Although motion can be limited
through modulation of respiration, it can also be accounted
for through use of medical imaging in the treatment room
for real-time localization of the tumor.6 ViewRay Inc (Cleveland, OH) designed a Co-60 based integrated magnetic resonance (MR) 0.35 T−guided radiation delivery system in
2012 and subsequently was able to substitute the radioactive
cobalt-based system with a 6MV linear accelerator (linac)
−based integrated MR-guided system in 2017.7 The Unity
system (Elekta A.B., Stockholm, Sweden; Philips N.V.,
Amsterdam, Netherlands) is another linac in clinical use
with on-board 1.5 T imaging capability.8 The ability to
obtain MR images during radiation treatments with these
integrated systems allows better soft-tissue visualization and
online adaptive treatment planning, and some systems allow
real-time imaging-based treatment gating. Lesions can be
tracked in real time (currently up to 8 frames/s) and respiratory gating can be performed based on internal anatomy.
This technology has shown promise in facilitating delivery
of dose-escalated stereotactic radiation treatments, where
enhanced visualization of tumors and surrounding organs at
risk allows for greater certainty of structure boundaries.
Onboard magnetic resonance imaging (MRI) also provides
near real-time veriﬁcation of breath hold reliability,9 which
has been used clinically in treatments of tumors of the abdomen and thorax.9-16 Nevertheless, challenges that remain
include the need for repeated breath holds during the course

of these treatment sessions to deliver the daily dose and
improving overall patient compliance. One intervention
shown to improve reproducibility is incorporating audiovisual biofeedback17 or real-time coaching.
Continuous positive airway pressure (CPAP) has been
used widely and safely in patients in an ambulatory and
home-care setting, most notably in the management of
obstructive sleep apnea.18 The CPAP device ﬁlters room
air and uses a compressor to generate a set pressure of air
which is subsequently delivered via nasal pillow, full face
mask, or hybrid mask. This constant level of pressure
throughout the respiratory cycle splints open the upper
airway and prevents dynamic collapse. This mechanism
has also been used sparingly in the radiation oncology setting as it is associated with increased end-expiratory volumes and decreased respiratory rate; however, it may also
introduce larger tidal volumes and greater diaphragmatic
movement.19 A number of published early clinical experiences have reported deploying CPAP as a cost-effective
and readily available respiratory management strategy
during radiation therapy.20-27 Here, the present work
investigates the compatibility of the CPAP system with an
MR-linac system while using the onboard MRI to characterize geometric changes and image quality under different CPAP-aided and DIBH conditions. Of signiﬁcant
interest was the effect of using CPAP as an adjunct to
DIBH goal of investigating the interaction between breath
holds and external airway pressure.

Methods and Materials
The ResMed S9 CPAP (ResMed Inc, San Diego, CA)
was used to provide airway pressures. The heated humidiﬁer attachment was not used in this study. The CPAP was
placed in a radiofrequency shielded closet near the ViewRay MR-linac and a 5-circuit (7.3 m) conﬁguration of single-use extension tubing was ﬁtted through a shielded
waveguide to yield the necessary length to reach the center
of the MRI bore. CPAP linearity (response between inputted cm H20 setting and measured with a manometer) of
the 5-circuit conﬁguration was obtained before each volunteer imaging session. Reproducibility (repeated measures at
0, 15, and 20 cm-H20) data were obtained to characterize
the device reliability. A baseline correction of + 2 cm-H20
was necessary for all pressure settings.
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Figure 1 Healthy volunteer setup for continuous positive airway pressure (CPAP) evaluation in a magnetic resonance

−guided radiation therapy environment (A) including the torso coils, immobilization devices, CPAP mask,
and (B) circuit tubing that was run through a waveguide to a radiofrequency shielded closet between the CPAP machine
and magnetic resonance imaging room.

With each volunteer study, a new 5-circuit tubing conﬁguration was built and before imaging studies, actual delivered airway pressures were recorded at each planned level of
pressure: 0, 6, 10, 12, and 15 cm H2O to ensure build reliability. Healthy volunteers at our institution were enrolled
from October 2019 through February 2020 to participate in
an institutional review board−approved pilot study. The
study was halted in March 2020 because of the COVID-19
pandemic, and further recruitment was not possible given
the respiratory nature of the study. Participants were adults
(age >18) who provided study-speciﬁc informed consent;
individuals were excluded if they had history of recent
esophageal surgery, chronic obstructive pulmonary disease,
heart failure, recent facial trauma or facial surgery, psychiatric limitations preventing MRI or CPAP mask, current pregnancy, MRI-incompatible implants, or inability to provide
consent. Registration was done only after eligibility assessment was complete and criteria were met, including MRI
safety screening. A total of 6 adult males met the inclusion
criteria and participated in the study.
Volunteers were then ﬁtted by a physician or respiratory therapist with an oronasal facemask (Phillips Respironics Inc, Murrysville, PA). Initial comfort and
tolerability testing was conducted by applying CPAP at
pressures of 0 cm H2O up to 15 cm H2O. After 2 minutes
at each pressure, volunteers were asked if the current
pressure was tolerable and if they would be willing to raise
the pressure to the next setting. All volunteers then completed a 6-question subjective survey graded on a 10-point
scale (1 strongly disagree to 10 strongly agree), with 3
questions pertaining to patient comfort and the other 3
questions to patient attitudes and perceptions of their
CPAP experience.
After the initial CPAP tolerability evaluation, thoracic
images were obtained using the MRIdian ViewRay MR-

guided linac (double-donut superconducting 70 cm wide
bore, 0.35 T 50 cm FOV magnet). Torso MRI coils, CPAP
mask, and ear protection were placed and secured. Participants were imaged lying supine, head-ﬁrst into the bore,
with arms holding a foam ring at the abdomen and with a
knee sponge for comfort as shown in Figure 1. Volumetric
MRIs were obtained at each pressure level with a 25-second free breathing (FB) scan followed by 2 repeated 25second
DIBH
scans
(25
second
TrueFISP,
1.5 £ 1.5 £ 3 mm3 resolution). Breath holds were
coached by verbal instruction without audio-visual feedback. After the imaging session, the participants completed the same survey that was administered after the
initial CPAP tolerability evaluation. The heart, left lung,
and right lung were contoured by a radiation oncologist
on the MR images in MIM version 6.8.7 (MIM Software
Inc, Cleveland, OH) and subsequently reviewed by a medical physicist. Volumes and positional centroids of heart
and lungs were automatically extracted using an in-house
script. Organ displacement was determined by rigid registration (translations only) based on bony anatomy to
establish a mutual coordinate system between successive
data sets to the reference condition (FB-0 cm H2O).
The presence of motion artifacts was assessed by a consensus of 2 scorers (a radiation oncologist and a medical
physicist) for each data set acquired. The scorers were
blinded as to which image was being shown and the
motion-associated liver dome artifact was graded on a
scale from 0 to 2. A score of 0 was assigned to images
with no appreciable motion artifact blurring, a score of 1
to images with mild-moderate motion artifact blurring,
and a score of 2 to images with major motion artifact
thereby limiting clinical use. For breath hold conditions at
which 2 images were obtained, the average motion artifact
score was calculated.
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Scores from participant questionnaires before and after imaging (N = 6)
Preimaging mean
(SD, range)

Postimaging mean
(SD, range)

P value

How much difﬁculty did you have tolerating CPAP?

2.8 (1.3, 1-5)

2.0 (1.1, 1-4)

.04*

How uncomfortable was the mask?

2.2 (1.6, 1-5)

2.2 (1.2, 1-4)

1

How uncomfortable was the pressure?

3.5 (1.2, 3-6)

2.2 (1.9, 1-6)

.01*

What is the likelihood of you wearing the equipment for radiation
treatment?

7.7 (1.6, 5-10)

9.0 (1.3, 8-10)

.16

How beneﬁcial do you think the CPAP is going to be for side effects
from the radiation?

7.2 (2.6, 4-10)

8.0 (1.7, 6-10)

.09

What is your attitude toward CPAP therapy?

8.2 (1.9, 5-10)

9.0 (1.3, 7-10)

.18

Comfort questions (10 = most uncomfortable, 1 = least uncomfortable)

Attitude questions (10 = most favorable, 1 = least favorable):

Abbreviations: CPAP = continuous positive airway pressure; SD = standard deviation.
* Indicates P < .05.
Student 2-tailed paired t tests were used to generate P values.

Paired t tests were performed to compare the mean difference of lung and heart volumes to the baseline volumes
at the reference condition. A similar analysis was performed on heart centroid displacement. Reference volumes and centroid locations for comparison were deﬁned
at the FB-0 cm H2O condition, similar to the standard
established in other CPAP studies.20,23,24,27 Additional
comparisons were done for FB-15 cm H2O versus DIBH0 cm H2O as well as DIBH-0 cm H2O versus DIBH15 cm H2O to assess the relative magnitude of geometric
changes associated with CPAP alone, DIBH alone, and
the combination of the 2. Paired t tests were also used to
compare the subjective artifact grades of images at all conditions to the artifact grades of the reference condition
image. A statistically signiﬁcant difference was detected if
the P value was less than .05 with 2-tailed paired t tests.
The effect of CPAP on repeatability of breath hold was
analyzed by comparing total lung volumes and superior/
inferior heart centroid location of 2 consecutive breath
holds at each pressure. Intraclass correlation coefﬁcients
(ICC) and their 95% conﬁdence intervals (CI) were calculated to measure the variation in total lung volumes and
inferior heart displacement as surrogates for repeatable
breath holds. An ICC of 0 indicates no repeatability and
an ICC of 1 indicates total repeatability; ICC values above
0.9 suggest excellent repeatability.

Results
A total of 6 healthy adult participants were enrolled in
this pilot study from October 2019 through February
2020. All participants were males with a median age of
38 years (range, 28-54 years) and mean weight of 92 kg
(range, 75-127 kg). All participants were able to tolerate
CPAP up to the maximum pressure of 15 cm H2O in

both the CPAP tolerability evaluation and imaging sessions. Participant survey results from the prescan (during
ﬁt testing) and postscan questionnaires are summarized
in Table 1. For questions that queried comfort, participants noted that they had less perceived difﬁculty tolerating CPAP after the imaging session compared with before
the scan (P = .04). There was no change in mask comfort
between the 2 surveys, but subjects were more acclimated
to the pressure at the latter time point, with higher perceived comfort after the scan (P = .01). Attitude and perception questions are also shown in Table 1; none of these
showed signiﬁcantly different changes.
Of the 6 volunteers, 2 did not have images obtained at
6 cm H2O pressure to reduce overall image study time
but had images for all other pressures included in the ﬁnal
analysis. Anatomic changes seen with selected CPAP,
breath hold, and combined conditions are shown with
image overlays in Figure 2. Table 2 summarizes the geometric changes associated with these conditions. At FB-6,
10, 12, and 15 cm H2O pressure, a mean total lung volume
increase relative to the baseline reference condition (FB0 cm H2O) was observed of 14% (P = .16), 29% (P = .02),
34% (P = .01), and 44% (P < .01), respectively. An even
greater increase in lung volume was seen with DIBH0 cm H2O, with a mean volume increase over baseline of
105%. Not only was this signiﬁcant compared with baseline (P < .01), but it was also greater than the volume
increase seen with FB-15 cm H2O (P = .01). A 130%
increase in lung volume over baseline was seen with
CPAP-aided breath hold (DIBH-15 cm H2O), greater
than with breath hold alone (DIBH-0 cm H2O; P < .01).
Decreases in heart volume with CPAP alone and with
breath hold alone did not reach statistical signiﬁcance,
but the decrease did reach signiﬁcance with CPAP levels
of ≥10 cm H2O applied together with a breath hold. With
CPAP-aided DIBH at 10, 12, and 15 cm H2O, the mean
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Figure 2 Low-ﬁeld magnetic resonance images from a healthy volunteer illustrating the effect of continuous positive air-

way pressure (CPAP) on lung and heart positioning. (A) The lung and heart under free breathing (FB) conditions (FB-0
cm H2O). (B) A deep inspiratory breath hold (DIBH) without positive airway pressure (DIBH-0 cm H2O).
Similarly, (C) shows FB-15 cm H2O and (D) shows DIBH-15 cm H2O. The color-coded overlay images (E, F, G,
H) demonstrate direct comparisons in lung and heart volumes when applying CPAP pressures (between 0 cm H2O and
15 cm H2O) and breath-hold state (FB or DIBH), highlighting the increased lung volumes and inferior heart shift.
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2.18 (0.59)y

Abbreviations: DIBH = deep inspiratory breath hold; FB = free breathing; ref. = reference.
* Indicates P < .05.
y Indicates P < .01.
z Shift in location of heart relative to position of heart centroid at reference condition. Positive values deﬁned as left, superior, and superior shifts.
Pressures delivered with continuous positive airway pressure (CPAP). Student 2-tailed paired t tests compared with reference condition (FB at CPAP 0 cm H2O).

2.11 (0.61)y
2.08 (0.58)y
1.94 (0.56)y
1.18 (0.71)y
0.96
(0.54)y
0.86 (0.53)*
ref.
Superior/inferior (cm)

0.57 (0.59)

1.97 (0.60)y

1.59 (1.41)y

0.55 (1.50)
0.58 (1.49)

1.54 (1.48)y
1.19 (1.53)y
0.51 (1.19)*

0.28 (1.50)
0.11 (1.21)

1.61 (1.39)y

0.46 (1.50)
0.38 (1.71)

0.34 (1.41)*

0.28 (1.20)

0.28 (1.58)

ref.
Anterior/posterior (cm)

0.38 (1.00)*

ref.
Lateral (cm)

Heart shiftz

% D heart volume

0.02 (1.35)

0.27 (1.69)

1.42 (1.61)y

664 (98)

12% (9%)*

668 (89)

12% (7%)*

660 (93)

12% (7%)y

678 (53)
729 (97)

4% (7%)

11% (7%)

707 (134)

5% (9%)

729 (129)

2% (9%)

757 (132)

1% (10%)
ref.

Heart volume (cc)

769 (134)
763 (82)

% D lung volume

1% (10%)

131% (51%)y

5936 (408)
5831 (435)

126% (47%)y
123% (53%)y

5715 (361)
5874 (372)

129% (52%)y

5278 (253)

105% (45%)y

3849 (974)

44% (27%)y

3583 (948)

29% (23%)*
ref.

Lung volume (cc)

14% (18%)

2671 (582)

N=6

3091 (821)

3437 (816)

34% (23%)*

DIBH-6 cm
H2O
mean (SD)
DIBH-0 cm
H2O
mean (SD)
FB-15 cm
H2O
mean (SD)
FB-12 cm
H2O
mean (SD)
FB-10 cm
H2O
mean (SD)
FB-6 cm H2O
mean (SD)
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FB-0 cm
H2O
mean (SD)

Table 2

Cardiothoracic anatomic geometry measurements under different respiratory management techniques

DIBH-10 cm
H2O
mean (SD)

DIBH-12 cm
H2O
mean (SD)

DIBH-15 cm
H2O
mean (SD)

E. Liang et al

heart volumes decreased by 12% (standard deviation [SD]
7%, P < .01), 12% (SD 7%, P = .01), and 12% (SD 9%,
P = .01), respectively.
Inferior and posterior displacements of the heart were
observed without signiﬁcant shift in the medial or lateral
axis. This information is also summarized in Table 2 with
signiﬁcance relative to reference FB-0 cm H2O shown.
Comparing FB-15 cm H2O to DIBH-0 cm H2O, DIBH
trended toward greater magnitude shifts, although only
signiﬁcantly in the posterior direction and not in the inferior direction (mean shift posterior 0.51 cm vs 1.19 cm,
P = .05; mean shift inferior 1.18 cm vs 1.94 cm, P = .11).
The addition of pressure in DIBH-15 cm H2O had the
greatest effect on the heart position and was signiﬁcantly
greater than DIBH-0 cm H2O (mean shift posterior
1.59 cm vs 1.19 cm, P = .03; mean shift inferior 2.18 cm
vs 1.94 cm, P = .20).
Table 3 best summarizes the differences in repeated
lung volumes with varied pressures. Of note, the lung volumes of 2 consecutive breath holds were more consistent
with CPAP DIBH-15 cm H2O (mean difference 69 cm3,
ICC = 0.97) than at DIBH-0 cm H2O (mean difference
408 cm3, ICC = 0.00). No change in heart position repeatability was seen, with mean heart superior-inferior centroid location differences of <1.5 mm across the cohort.
Table 4 lists the consensus motion artifact scores
assigned to each set of images. No motion artifact was
seen for any of the breath hold images, with all images
scoring 0, which was signiﬁcantly different from the reference condition (mean artifact score of 1.83). As expected,
adding substantial CPAP pressure (15 cm H2O) yielded a
statistically signiﬁcant difference from baseline free
breathing conditions (P = .03).

Discussion
In the present study, we showed the compatibility of
using CPAP for potential applications on an MR-guided
radiation treatment (MRgRT) machine. Unlike previous
studies that compared FB images with CPAP at one set
pressure, one distinct beneﬁt of our study is that by implementing MRI, we had the ability to study varying levels of
pressure relative to free breathing and breath hold alone,
as well as the potential use of CPAP-aided DIBH. Overall,
the approach was well-tolerated, with participants getting
more acclimated to the airway pressure after the imaging
session. Increased CPAP pressures predictably increased
lung volumes and shifted the heart inferiorly and posteriorly. However, implementing CPAP alone led to anatomic
shifts that were smaller in magnitude, less lung volume
increase, and resulted in images with more motion artifact
compared with DIBH alone. This suggests that CPAP in a
FB setting may not be as robust for use in MRgRT and
may not be a suitable substitute for DIBH. Nevertheless,
for patients who are unable to tolerate a breath-hold,
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Reproducibility of anatomic changes in consecutive breath holds under different CPAP-applied pressures

N=6

0 cm H2O

6 cm H2O

10 cm H2O

12 cm H2O

15 cm H2O

Mean absolute D lung volume (SD), cc

408 (392)

198 (126)

321 (169)

126 (136)

69 (70)

Correlation coefﬁcient* (95% CI)

0.00 (0.00-0.00) 0.78 (0.27-0.97) 0.57 (0.13-0.92) 0.91 (0.61-0.98) 0.97 (0.87-0.99)

Mean absolute sup/inf heart shift (SD), cm 0.13 (0.12)
Correlation coefﬁcient* (95% CI)

0.12 (0.06)

0.12 (0.09)

0.14 (0.09)

0.11 (0.06)

0.95 (0.77-0.99) 0.97 (0.81-1.00) 0.96 (0.83-0.99) 0.96 (0.82-0.99) 0.97 (0.87-0.99)

Abbreviations: CI = conﬁdence interval; CPAP = continuous positive airway pressure; SD = standard deviation; sup/inf = superior/inferior.
* Intraclass correlation coefﬁcient, where 0 signiﬁes no reliability between repeated measurements and 1 signiﬁes perfect reliability.

CPAP coupled with FB may provide some cardioprotection, as evidenced by favorable centroid shifts compared
with FB alone. The combination of CPAP-aided DIBH
led to the greatest degree of lung volume expansion and
inferior or posterior shift of the heart. More importantly,
the reproducibility results showed that CPAP-aided
DIBH yielded more consistent lung volumes, suggesting
potential for improving the reproducibility of breath
holds.
Several published studies under CT imaging conditions
have examined the role of CPAP use during radiation
treatment planning and delivery. A pilot study by Goldstein et al looking at stereotactic body radiation therapy
(SBRT) for lung tumors under 8 to 15 cm H2O CPAP
showed a relative lung volume increase of 32% compared
with standard FB.20 Two clinical trials of women receiving
left-sided breast radiation therapy highlighted that implementing CPAP led to increases of total lung volume by
35% and 60%, achieved with 8 to 15 cm H2O and 20 cm
H2O, respectively.24,27 One previous study of SBRT
patients showed a lesser degree of 8% lung volume
increase.23 The authors of this study partly attribute the
decreased volume increase to the CPAP pressure (average
6.9 cm H2O) being less than the pressures in other studies.
Our study corroborates this explanation, with no statistically signiﬁcant lung volume increase seen with FB-6 cm
H2O and a 44% lung volume increase seen with FB-15 cm
Table 4

H2O. This also suggests that for CPAP to be beneﬁcial in
this setting, ample pressure must be provided, although
these settings may depend on overall tolerability of the
pressure settings. However, we saw an even greater magnitude of lung volume increase to 105% above baseline
with breath hold alone and 131% above baseline with
DIBH-15 cm H2O. This ﬁnding was also shown in
another recent study investigating the combination of
DIBH + CPAP, with lung volume increase of about 100%
with DIBH at 15 cm H2O.28
Decrease in heart volume and posteroinferior heart
displacement are additional beneﬁts seen with the
application of CPAP. In the previous reported clinical
experiences with CPAP, a minimal average 26 cm3
decrease was seen in one study, and no heart volume
difference was seen in another.20,27 We similarly did
not see any signiﬁcant change in heart volume with
CPAP alone. However, with DIBH in conjunction with
CPAP, we were able to see a 12% decrease in heart
volume at DIBH-15 cm H2O. The other
DIBH + CPAP study showed a 9.5% decrease in heart
volume at this condition. In addition, our study looked
at the shift in the heart centroid relative to the centroid at the free breathing condition, and we saw posterior and inferior shifts associated with application of
CPAP, greater shifts associated with DIBH, and the
greatest shifts with the combination.

Image artifact scores

Participant
(N = 6)

FB-0
cm H2O

FB-6
cm H2O

FB-10
cm H2O

FB-12
cm H2O

FB-15
cm H2O

DIBH-0
cm H2O

DIBH-6
cm H2O

DIBH-10
cm H2O

DIBH-12
cm H2O

DIBH-15
cm H2O

1

1

1

1

2

1

0

0

0

0

0

2

2

N/A

2

1

2

0

N/A

0

0

0

3

2

N/A

1

1

1

0

N/A

0

0

0

4

2

2

2

1

1

0

0

0

0

0

5

2

1

1

1

1

0

0

0

0

0

6

2

1

1

1

1

0

0

0

0

0

Mean

1.83

1.25

1.33

1.17

1.17

0

0

0

0

0

t Test P value

ref.

0.18

0.08

0.10

0.03

<0.01

<0.01

<0.01

<0.01

<0.01

Abbreviations: DIBH = deep inspiratory breath hold; FB = free breathing; N/A = not available.
Pressures delivered with continuous positive airway pressure. Scores were deﬁned to the blinded graders as 0: no motion artifact; 1: minor motion
artifact; 2: major motion artifact. Deep inspiratory breath hold scores were obtained by averaging the scores from the ﬁrst trial and second trial.
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In the clinical setting, other studies have shown the clinical beneﬁts of these geometric changes. Improvement in
lung dose and heart dose parameters was demonstrated in
these experiences,20,24,27,28 highlighting future opportunities to quantify the dosimetric beneﬁts of CPAP-guided
MRgRT. In the case of SBRT treatment of lung tumors, the
planned target volumes were decreased by 19% to 24%
with administration of CPAP.20,29 Another notable takeaway in one study was that radiation therapy with CPAP
did not increase treatment setup time compared with freebreathing setup, and the authors concluded CPAP may be
a viable option for respiratory management in resourcelimited radiation oncology centers.24 Another clinical question that arises is the viability of CPAP in the population of
patients with thoracic malignancies who often have underlying pulmonary comorbidities. In the case of chronic
obstructive pulmonary disease, use of CPAP has been
shown in a prospective trial to increase 5-year survival
among patients with both chronic obstructive pulmonary
disease and concurrent obstructive sleep apnea.30 In one
prospective trial with 40 patients investigating CPAP for
treatment of lung tumors, left-sided breast cancer, or liver
metastases, 10 of the patients had underlying chronic
obstructive pulmonary disease as well. The volumetric beneﬁts of CPAP were also seen in this subgroup.29
MRgRT is an evolving technology which can provide
real-time direct visualization of tumors and superior soft
tissue delineation capabilities. It has been used in the clinical setting with intracranial, head and neck, lung, abdominal, and pelvic tumors, allowing for decreased setup
margins and the potential for decreased normal tissue
toxicity.31 For abdominal and pelvic tumors, it may help
patients avoid potential complications with placement of
ﬁducial markers that would otherwise be necessary for
safe delivery of radiation. In our study, we show that
CPAP is a tool that could be implemented in the MRgRT
setting. Although MRgRT is typically located in resourcerich centers, there may still be a role for CPAP. Our study
showed less motion artifact with the addition of CPAP
and more consistent lung volumes with higher CPAP settings. This may be due to the need for less force applied
by the diaphragm with the pressure support of the CPAP
machine and thus, less patient fatigue. More reproducible
holds offer the possibility of shorter treatment times associated with gated radiation therapy, which can be
explored in future work. Reckhow et al described their
experience with patients who had difﬁculty tolerating
DIBH alone were able to endure CPAP-aided DIBH.28
Although the CPAP-aided DIBH did signiﬁcantly reduce
mean heart dose and mean lung dose more than DIBH
alone, the authors also hypothesized that adding CPAP to
DIBH could reduce the respiratory effort needed by
patients for DIBH. Patient compliance with MRgRT sessions frequently depends on the ability to reliably reproduce breath holds, and these studies suggest that CPAP
could be worthy of further investigation as an MR-
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compatible breath hold aid. It would represent a potential
way to safely treat patients with intrathoracic or upper
abdominal tumors who would not otherwise be candidates for MRgRT due to poor tolerability of DIBH.
CPAP is not the only respiratory approach that has
been considered for facilitating breath holds in the radiation therapy setting. Other studies have looked at the use
of mechanical ventilation for both more controlled
breathing patterns and more sustained breath holds.32,33
One such study revealed breath holds with mean duration
time of 6 minutes with preparatory mechanical hyperventilation before breath hold. Another approach is to use
high frequency ventilatory strategies occasionally used in
the intensive care unit as a way to oxygenate patients
without causing much diaphragmatic movement. One
series of publications described a technique for limiting
liver tumor movement to 3 mm in the setting of singledose SBRT treatments with the aid of high frequency jet
ventilation and gold marker ﬁducials.34,35 High frequency
percussive ventilation has also been used to create sustained breath holds, with rapid (300-600 breath/min) percussive breaths helping to oxygenate patients during
breath holds of 5 to 11 minutes.36,37 One retrospective
study described the effect of using high frequency percussive ventilation in the treatment of thoracic Hodgkin lymphoma and showed a decrease in cardiac dose.38
Although these breath hold durations offer strong potential, these respiratory interventions are much less widespread than CPAP and have thus far been mostly limited
to investigational settings.
The present study does have clear limitations in its small
sample set of healthy participants. However, using each
participant as their own control, allowed accurate characterization of geometric changes after CPAP. Each participant was able to reliably perform coached DIBH, and
when in practice, the combination CPAP-aided DIBH
approach may be more relevant for those patients who are
borderline candidates for DIBH who would otherwise be
ineligible due to fatigue and reproducibility limitations.
Reproducibility was based on 2 consecutive breath holds,
whereas a typical fraction of radiation can require 7 to 9
DIBHs of 20 seconds each.39 In addition, this study only
looked at intrafraction repeatability, whereas interfractional
changes in body positioning and target position are also of
great relevance. Future studies may include assessment of
breath hold duration with and without CPAP in the treatment position and of tolerability in a clinical patient population less able to maintain DIBH.

Conclusion
In this initial feasibility study, integrating CPAP into an
MR-linac for healthy volunteers demonstrated increasing
heart displacement and lung volume as well as decreased
associated image artifact. CPAP-aided DIBH also resulted
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in geometric changes of greater magnitude, and less volume difference between consecutive breath holds. Overall,
CPAP was found to be compatible with the MR-guided
radiation treatment clinical environment and was well-tolerated by the volunteer cohort. With conﬁrmation of these
ﬁndings in a larger patient cohort, clinical effectiveness can
be further evaluated.
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